XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities        
Net loss $ (6,280,066) $ (2,482,605) $ (17,036,837) $ (11,843,513)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation and amortization expense 159,461 159,461 687,845 478,191
Bad debt expense 16,963 11,250 12,000 23,500
Impairment expense       3,113,020
Gain on forgiveness of debt (24,925) 0 (376,177)  
Equity based compensation expense 502,407 870,722 3,212,772 4,643,127
Recognized loss (gain) on marketable securities (223) 18,786 22,416 160,449
Gain on sale of asset       (27,000)
Marketable securities distributed as compensation     3,917  
Expenses paid through financings     32,500 15,000
Loan principal paid directly through grant (2,992) 0 (8,853)
Amortization of debt discount and debt costs 1,309,212 31,976 1,840,745 39,372
Initial derivative expense 3,585,983 0 3,340,554
Change in derivative value due to anti-dilution adjustments     2,642,175
Change in fair value of derivative liability (628,621) 565,088 2,658,261 (1,138,604)
Changes in operating assets and liabilities:        
(Increase) decrease in accounts receivable (854,522) 9,749 (94,767) (58,804)
Increase in accounts receivable – related party (3,259) (5,942) (36,784) (4,340)
(Increase) decrease in prepaid expenses and other current assets 28,923 (19,954) (68,542) (73,620)
Increase in accounts payable and accrued liabilities 643,270 387,823 626,895 2,752,033
Increase (decrease) in accounts payable and accrued liabilities – related parties 136,448 324,073 (63,863) 507,425
Increase in other liabilities 0 51,780 173,525
Increase (decrease) in deferred revenue 87,845 (15,434) (93,937) 22,906
Net cash used in operating activities (1,324,096) (93,227) (2,526,155) (1,390,858)
Cash Flows from Investing Activities        
Proceeds from sale of marketable securities 0 14,955 17,009 68,702
Cash paid for acquisitions, net of cash assumed (249,983) 0    
Cash paid for customer contracts     (50,000)
Proceeds from sale of asset       27,000
Cash paid for equipment     (3,463)
Cash paid for software development     (11,500)
Net cash provided (used) by investing activities (249,983) 14,955 (32,991) 80,739
Cash Flows from Financing Activities        
Proceeds from loans 250,000   398,545 45,005
Proceeds from convertible notes 2,153,200 0 2,476,000
Payments of notes (5,767) (4,984) (17,907) (105,034)
Advances on receivables 0 180,778 180,778
Repayments of advances on receivables     (180,778)
Proceeds from sale of future revenues       424,510
Repayments of sale of future revenues (10,904) (127,241) (528,838) (27,259)
Deposit on purchase of preferred stock 0 25,000 500,000
Repayment of deposit on purchase of preferred stock     (215,000)
Proceeds from sale of preferred stock     25,000 979,997
Net cash provided by financing activities 2,136,529 73,553 2,352,800 1,602,219
Net increase (decrease) in cash 562,450 (4,719) (206,346) 292,100
Cash, beginning of year 99,906 306,252 306,252 14,152
Cash, end of year 662,356 301,533 99,906 306,252
Supplemental disclosures of cash flow information:        
Cash paid during the year for interest 63,746 38,721 235,813 49,552
Cash paid during the year for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:        
Original issue discount deducted from convertible note proceeds 342,554 0 328,125
Debt costs deducted from convertible note proceeds 334,800 0 366,500
Contingent consideration for acquisitions 1,974,377 0    
Preferred stock issued for accrued penalties 0 1,929,516 1,929,516
Notes and accrued interest converted to common stock 285,939 0 96,000  
Common stock issued/to be issued for asset acquisition 3,520,171 0    
Notes payable and accrued interest exchanged for debentures 252,430 0    
Preferred stock issued for asset acquisition     8,600,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary     2,059,764
Notes payable and accrued interest exchanged for preferred stock     116,380
Noncontrolling interest reclassified to paid-in capital       1,591,221
Accounts payable paid through proceeds of preferred stock     100,000
Accrued compensation paid with common stock 16,425 0 56,250
Warrant derivative liability extinguished 373,070 0    
Liabilities assumed in acquisition 108,500 0    
Value of warrant issued with note     42,000
Accounts payable paid through proceeds of note     4,995
Warrant derivative liability at inception 5,960,058 0 5,625,519 1,750,646
Accrued compensation forgiven and credited to contributed capital     187,500
Discount attributable to liability on sale future revenues       142,491
Discount attributable to note payable       10,000
Marketable securities received as payment for Series D preferred stock $ 0 $ 0 240,000
Notes and accrued interest forgiven     $ 706,501